Martyna Kadłubańska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Martyna Kadłubańska has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Anna Kuls
Polish Red Cross Maritime Hospital, Gdynia, Poland
10 shared publications - Aleksandra Zofia Sobol
Szpital św. Wincentego a Paulo in Gdynia, Gdynia, Poland
10 shared publications - Anna Maria Kowalska
Szpitale Tczewskie SA, Tczew, Poland
10 shared publications - Bogusław Pabis
University Clinical Centre, Gdansk, Poland
10 shared publications - Justyna Maria Wiktorowicz
COPERNICUS, Adalbert Copernicus Hospital in Gdańsk, Gdańsk, Poland
10 shared publications - Nicole Bulińska
University Clinical Centre, Gdansk, Poland
10 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
THE ROLE OF SMARTPHONE GLUCOSE MONITORING APPS IN IMPROVING SELF-MANAGEMENT AMONG PATIENTS WITH TYPE 2 DIABETES
Type 2 diabetes remains one of the most common chronic diseases worldwide, and despite available treatment options, achieving optimal glycaemic control is still a challenge for many patients [1]. In recent years, the growing availability of smartphones and the development of continuous glucose monitoring (CGM) systems have created new opportunities to support daily self-management [6]. This narrative review aims to explore the role of smartphone-based glucose monitoring applications in the management of type 2 diabetes. The analysis is based on literature from PubMed and Google Scholar published between 2015 and 2026. The selected studies focused on the use of CGM systems integrated with mobile applications and their impact on clinical outcomes, patient adherence, and quality of life. The available evidence suggests that these technologies may improve glycaemic control, as reflected by reductions in HbA1c levels, increased time in range (TIR), and fewer episodes of hypo- and hyperglycaemia [14, 15]. In addition, they appear to support greater patient engagement and independence by providing real-time feedback and facilitating a better understanding of the relationship between lifestyle factors and glucose levels [6]. At the same time, several limitations need to be considered, including unequal access to technology and cost-related barriers [10]. Overall, smartphone-based CGM applications seem to be a valuable addition to standard diabetes care, although their effectiveness depends on proper implementation and long-term use.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessTHE ROLE OF SMARTPHONE GLUCOSE MONITORING APPS IN IMPROVING SELF-MANAGEMENT AMONG PATIENTS WITH TYPE 2 DIABETES
Type 2 diabetes remains one of the most common chronic diseases worldwide, and despite available treatment options, achieving optimal glycaemic control is still a challenge for many patients [1]. In recent years, the growing availability of smartphones and the development of continuous glucose monitoring (CGM) systems have created new opportunities to support daily self-management [6]. This narrative review aims to explore the role of smartphone-based glucose monitoring applications in the management of type 2 diabetes. The analysis is based on literature from PubMed and Google Scholar published between 2015 and 2026. The selected studies focused on the use of CGM systems integrated with mobile applications and their impact on clinical outcomes, patient adherence, and quality of life. The available evidence suggests that these technologies may improve glycaemic control, as reflected by reductions in HbA1c levels, increased time in range (TIR), and fewer episodes of hypo- and hyperglycaemia [14, 15]. In addition, they appear to support greater patient engagement and independence by providing real-time feedback and facilitating a better understanding of the relationship between lifestyle factors and glucose levels [6]. At the same time, several limitations need to be considered, including unequal access to technology and cost-related barriers [10]. Overall, smartphone-based CGM applications seem to be a valuable addition to standard diabetes care, although their effectiveness depends on proper implementation and long-term use.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
LICHEN SCLEROSUS – EPIDEMIOLOGY, TREATMENT, IMPACT ON QUALITY OF LIFE AND EMERGING THERAPEUTIC APPROACHES - A REVIEW
Lichen sclerosus (LS) is a chronic, inflammatory skin disease with a complex, multifactorial etiology, encompassing immunological, genetic, hormonal, and environmental factors. The disease most commonly affects the anogenital region, leading to characteristic porcelain-white, atrophic plaques that can cause anatomical deformities, scarring, and impairments in sexual and urological function. LS symptoms are variable and include pruritus, pain, dyspareunia, urinary and bowel disturbances, as well as extragenital lesions in keratotic, bullous, or annular forms. The prevalence of LS differs between children and adults, and diagnostic delays can range from several months up to five years, increasing the risk of complications, including squamous cell carcinoma of the genital organs. Diagnosis is primarily based on clinical examination, dermoscopy, and, in ambiguous cases, skin biopsy. Standard treatment includes topical glucocorticosteroids, with the possibility of maintenance therapy and adjunctive approaches such as calcineurin inhibitors, laser therapies, or systemic acitretin. Due to the chronic course of the disease and its impact on quality of life, patient care should be multidisciplinary, incorporating psychological support, sexual counseling and patient education. The aim of this study is to provide a comprehensive overview of the clinical manifestations, diagnostic methods, therapeutic strategies, and consequences of LS for patient functioning. Emphasizing the importance of early diagnosis, monitoring of lesions, and patient education may contribute to improved treatment outcomes and quality of life for affected individuals.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessLICHEN SCLEROSUS – EPIDEMIOLOGY, TREATMENT, IMPACT ON QUALITY OF LIFE AND EMERGING THERAPEUTIC APPROACHES - A REVIEW
Lichen sclerosus (LS) is a chronic, inflammatory skin disease with a complex, multifactorial etiology, encompassing immunological, genetic, hormonal, and environmental factors. The disease most commonly affects the anogenital region, leading to characteristic porcelain-white, atrophic plaques that can cause anatomical deformities, scarring, and impairments in sexual and urological function. LS symptoms are variable and include pruritus, pain, dyspareunia, urinary and bowel disturbances, as well as extragenital lesions in keratotic, bullous, or annular forms. The prevalence of LS differs between children and adults, and diagnostic delays can range from several months up to five years, increasing the risk of complications, including squamous cell carcinoma of the genital organs. Diagnosis is primarily based on clinical examination, dermoscopy, and, in ambiguous cases, skin biopsy. Standard treatment includes topical glucocorticosteroids, with the possibility of maintenance therapy and adjunctive approaches such as calcineurin inhibitors, laser therapies, or systemic acitretin. Due to the chronic course of the disease and its impact on quality of life, patient care should be multidisciplinary, incorporating psychological support, sexual counseling and patient education. The aim of this study is to provide a comprehensive overview of the clinical manifestations, diagnostic methods, therapeutic strategies, and consequences of LS for patient functioning. Emphasizing the importance of early diagnosis, monitoring of lesions, and patient education may contribute to improved treatment outcomes and quality of life for affected individuals.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
CURRENT CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE - A NARRATIVE REVIEW
Dry eye disease (DED) is a chronic, multifactorial disorder of the ocular surface, the prevalence of which is steadily increasing with population aging and changes in lifestyle. The aim of this study was to review current knowledge on the epidemiology, pathophysiology, risk factors, symptoms, diagnosis, and treatment of DED, with particular emphasis on emerging therapeutic approaches. This is a review paper based on an analysis of available scientific literature from databases such as PubMed and Google Scholar. Original studies, systematic reviews, meta-analyses, and expert reports were included, including the TFOS DEWS II guidelines. The collected data indicate that DED affects between 5% and 50% of the population and occurs more frequently in women and older individuals. The pathogenesis of the disease involves disruption of ocular surface homeostasis, tear film instability and hyperosmolarity, and chronic inflammation, coexisting with neurosensory abnormalities. Environmental and behavioral factors play a significant role, particularly prolonged use of digital devices. Diagnosis remains challenging due to the weak correlation between symptoms and clinical findings. Management is multifaceted and includes symptomatic and anti-inflammatory therapy as well as lifestyle modifications; however, it often does not eliminate the underlying causes of the disease. The conclusions indicate that DED constitutes a significant clinical problem, and the development of targeted therapies and modern drug delivery systems may contribute to improved treatment efficacy in the future.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessCURRENT CONCEPTS IN THE DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE - A NARRATIVE REVIEW
Dry eye disease (DED) is a chronic, multifactorial disorder of the ocular surface, the prevalence of which is steadily increasing with population aging and changes in lifestyle. The aim of this study was to review current knowledge on the epidemiology, pathophysiology, risk factors, symptoms, diagnosis, and treatment of DED, with particular emphasis on emerging therapeutic approaches. This is a review paper based on an analysis of available scientific literature from databases such as PubMed and Google Scholar. Original studies, systematic reviews, meta-analyses, and expert reports were included, including the TFOS DEWS II guidelines. The collected data indicate that DED affects between 5% and 50% of the population and occurs more frequently in women and older individuals. The pathogenesis of the disease involves disruption of ocular surface homeostasis, tear film instability and hyperosmolarity, and chronic inflammation, coexisting with neurosensory abnormalities. Environmental and behavioral factors play a significant role, particularly prolonged use of digital devices. Diagnosis remains challenging due to the weak correlation between symptoms and clinical findings. Management is multifaceted and includes symptomatic and anti-inflammatory therapy as well as lifestyle modifications; however, it often does not eliminate the underlying causes of the disease. The conclusions indicate that DED constitutes a significant clinical problem, and the development of targeted therapies and modern drug delivery systems may contribute to improved treatment efficacy in the future.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
FOOD PRESERVATIVES AND HUMAN HEALTH: MOLECULAR MECHANISMS, CLINICAL CONSEQUENCES, AND PUBLIC HEALTH IMPLICATIONS: A NARRATIVE REVIEW
Introduction: Food preservatives are widely used in modern food systems to prevent microbial spoilage and extend shelf life. However, increasing evidence suggests that their long-term consumption may have implications for human health, particularly in relation to chronic non-communicable diseases. Common preservatives, including sodium benzoate, sulfites, and nitrate/nitrite compounds, may disrupt redox homeostasis, induce oxidative stress, alter gut microbiota, and activate pro-inflammatory pathways such as nuclear factor kappa B (NF-κB). Aim of the Study: This narrative review aims to synthesize current evidence on the biological effects of selected food preservatives, focusing on molecular mechanisms, clinical relevance, and public health implications. Materials and Methods: A narrative literature review was conducted using PubMed, Scopus, and Web of Science. Additional sources included reports from international organizations. Keywords such as “food preservatives,” “oxidative stress,” “gut microbiota,” and “inflammation” were used. Peer-reviewed articles published mainly between 2010 and 2026 were included. Results: Evidence indicates that preservatives may increase reactive oxygen species production and impair antioxidant defenses, leading to oxidative stress and cellular damage. They may also alter gut microbiota composition, reduce microbial diversity, and impair intestinal barrier function, promoting systemic inflammation. Activation of inflammatory pathways, including NF-κB signaling, has been reported. Epidemiological studies suggest an association between high intake of preservative-rich ultra-processed foods and an increased risk of metabolic disorders, cardiovascular diseases, and cancer. Conclusion: Food preservatives may affect human health through interconnected mechanisms involving oxidative stress, gut dysbiosis, and inflammation. These findings highlight the need for integrative risk assessment approaches and dietary strategies reducing ultra-processed food consumption.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessFOOD PRESERVATIVES AND HUMAN HEALTH: MOLECULAR MECHANISMS, CLINICAL CONSEQUENCES, AND PUBLIC HEALTH IMPLICATIONS: A NARRATIVE REVIEW
Introduction: Food preservatives are widely used in modern food systems to prevent microbial spoilage and extend shelf life. However, increasing evidence suggests that their long-term consumption may have implications for human health, particularly in relation to chronic non-communicable diseases. Common preservatives, including sodium benzoate, sulfites, and nitrate/nitrite compounds, may disrupt redox homeostasis, induce oxidative stress, alter gut microbiota, and activate pro-inflammatory pathways such as nuclear factor kappa B (NF-κB). Aim of the Study: This narrative review aims to synthesize current evidence on the biological effects of selected food preservatives, focusing on molecular mechanisms, clinical relevance, and public health implications. Materials and Methods: A narrative literature review was conducted using PubMed, Scopus, and Web of Science. Additional sources included reports from international organizations. Keywords such as “food preservatives,” “oxidative stress,” “gut microbiota,” and “inflammation” were used. Peer-reviewed articles published mainly between 2010 and 2026 were included. Results: Evidence indicates that preservatives may increase reactive oxygen species production and impair antioxidant defenses, leading to oxidative stress and cellular damage. They may also alter gut microbiota composition, reduce microbial diversity, and impair intestinal barrier function, promoting systemic inflammation. Activation of inflammatory pathways, including NF-κB signaling, has been reported. Epidemiological studies suggest an association between high intake of preservative-rich ultra-processed foods and an increased risk of metabolic disorders, cardiovascular diseases, and cancer. Conclusion: Food preservatives may affect human health through interconnected mechanisms involving oxidative stress, gut dysbiosis, and inflammation. These findings highlight the need for integrative risk assessment approaches and dietary strategies reducing ultra-processed food consumption.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
AUTOMATED DETECTION OF OUT-OF-HOSPITAL CARDIAC ARREST USING WEARABLE TECHNOLOGY: A SYSTEMATIC SCOPING REVIEW OF DIAGNOSTIC ACCURACY, REAL-WORLD FEASIBILITY, AND ETHICAL IMPLICATIONS
Out-of-hospital cardiac arrest (OHCA) is characterized by an exceptionally low survival rate, primarily due to delayed recognition in unwitnessed cases (Gräsner et al., 2021; Hutton et al., 2022). This scoping review aims to evaluate the diagnostic accuracy, real-world feasibility, and ethical implications of using commercial smartwatches for the automated detection of OHCA (Hutton et al., 2022; Eversdijk et al., 2024). Electronic databases (including PubMed and PMC) were searched for publications spanning 2019–2026, identifying high-quality studies in accordance with the PRISMA-ScR guidelines. The analysis focused on multimodal algorithms combining photoplethysmography (PPG) with triaxial accelerometry (Schober et al., 2022; Shah et al., 2025). Results indicate that these algorithms achieve a sensitivity of approximately 98% and a specificity of 99% in simulation studies (Schober et al., 2022). The first documented case reports confirm successful automated detections in real-world settings, demonstrating the potential to significantly reduce emergency medical services (EMS) response times (Edgar et al., 2026; Scquizzato et al., 2020; Eversdijk et al., 2024). Major identified barriers include motion artifacts, health disparities resulting from degraded PPG performance in individuals with darker skin tones, and the risk of alert fatigue caused by false-positive calls (Bent et al., 2020; Eversdijk et al., 2024; van der Eerden et al., 2025). Ethical integration necessitates the implementation of "dynamic consent" models to safeguard patient privacy (Kaye et al., 2015; Eversdijk et al., 2024). In conclusion, wearable devices represent a breakthrough tool capable of acting as "digital witnesses" to significantly strengthen the chain of survival (Schober et al., 2022; Semeraro et al., 2021). However, their widespread implementation requires AI-driven optimization, the mitigation of algorithmic biases, and rigorous integration with emergency dispatch systems (Scquizzato et al., 2020; Shah et al., 2025).
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessAUTOMATED DETECTION OF OUT-OF-HOSPITAL CARDIAC ARREST USING WEARABLE TECHNOLOGY: A SYSTEMATIC SCOPING REVIEW OF DIAGNOSTIC ACCURACY, REAL-WORLD FEASIBILITY, AND ETHICAL IMPLICATIONS
Out-of-hospital cardiac arrest (OHCA) is characterized by an exceptionally low survival rate, primarily due to delayed recognition in unwitnessed cases (Gräsner et al., 2021; Hutton et al., 2022). This scoping review aims to evaluate the diagnostic accuracy, real-world feasibility, and ethical implications of using commercial smartwatches for the automated detection of OHCA (Hutton et al., 2022; Eversdijk et al., 2024). Electronic databases (including PubMed and PMC) were searched for publications spanning 2019–2026, identifying high-quality studies in accordance with the PRISMA-ScR guidelines. The analysis focused on multimodal algorithms combining photoplethysmography (PPG) with triaxial accelerometry (Schober et al., 2022; Shah et al., 2025). Results indicate that these algorithms achieve a sensitivity of approximately 98% and a specificity of 99% in simulation studies (Schober et al., 2022). The first documented case reports confirm successful automated detections in real-world settings, demonstrating the potential to significantly reduce emergency medical services (EMS) response times (Edgar et al., 2026; Scquizzato et al., 2020; Eversdijk et al., 2024). Major identified barriers include motion artifacts, health disparities resulting from degraded PPG performance in individuals with darker skin tones, and the risk of alert fatigue caused by false-positive calls (Bent et al., 2020; Eversdijk et al., 2024; van der Eerden et al., 2025). Ethical integration necessitates the implementation of "dynamic consent" models to safeguard patient privacy (Kaye et al., 2015; Eversdijk et al., 2024). In conclusion, wearable devices represent a breakthrough tool capable of acting as "digital witnesses" to significantly strengthen the chain of survival (Schober et al., 2022; Semeraro et al., 2021). However, their widespread implementation requires AI-driven optimization, the mitigation of algorithmic biases, and rigorous integration with emergency dispatch systems (Scquizzato et al., 2020; Shah et al., 2025).
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
GLP-1 RECEPTOR AGONISTS VERSUS METFORMIN IN POLYCYSTIC OVARY SYNDROME: METABOLIC BENEFITS, REPRODUCTIVE OUTCOMES AND THE EVIDENCE GAP IN LEAN PCOS
Polycystic ovary syndrome (PCOS) is one of the most frequently diagnosed disorders that affects many women of reproductive age and is linked to both metabolic and reproductive problems. Metformin has been used for many years as a standard treatment for insulin resistance in PCOS, while glucagon-like peptide-1 (GLP-1) receptor agonists have recently gained interest because of their stronger effects on body weight and metabolism. The aim of this review was to compare the effects of GLP-1 receptor agonists and metformin in women with PCOS, with special attention to the lack of data in lean PCOS. Most studies show that GLP-1 receptor agonists lead to greater weight loss and larger reductions in body mass index, waist circumference, and insulin resistance compared with metformin, especially in women with overweight or obesity. However, when it comes to reproductive outcomes such as ovulation, menstrual regularity, or androgen levels, neither treatment clearly shows better results than the other. An important limitation of current research is that most studies include mainly overweight patients, while data on lean PCOS are still limited. Overall, GLP-1 receptor agonists seem to offer stronger metabolic benefits, while metformin remains a practical and commonly used first-line treatment, particularly in lean patients. More studies focusing on different PCOS phenotypes, especially lean PCOS, are needed to better guide treatment decisions.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessGLP-1 RECEPTOR AGONISTS VERSUS METFORMIN IN POLYCYSTIC OVARY SYNDROME: METABOLIC BENEFITS, REPRODUCTIVE OUTCOMES AND THE EVIDENCE GAP IN LEAN PCOS
Polycystic ovary syndrome (PCOS) is one of the most frequently diagnosed disorders that affects many women of reproductive age and is linked to both metabolic and reproductive problems. Metformin has been used for many years as a standard treatment for insulin resistance in PCOS, while glucagon-like peptide-1 (GLP-1) receptor agonists have recently gained interest because of their stronger effects on body weight and metabolism. The aim of this review was to compare the effects of GLP-1 receptor agonists and metformin in women with PCOS, with special attention to the lack of data in lean PCOS. Most studies show that GLP-1 receptor agonists lead to greater weight loss and larger reductions in body mass index, waist circumference, and insulin resistance compared with metformin, especially in women with overweight or obesity. However, when it comes to reproductive outcomes such as ovulation, menstrual regularity, or androgen levels, neither treatment clearly shows better results than the other. An important limitation of current research is that most studies include mainly overweight patients, while data on lean PCOS are still limited. Overall, GLP-1 receptor agonists seem to offer stronger metabolic benefits, while metformin remains a practical and commonly used first-line treatment, particularly in lean patients. More studies focusing on different PCOS phenotypes, especially lean PCOS, are needed to better guide treatment decisions.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
DETECTION WITHOUT DIRECTION: THE CLINICAL SIGNIFICANCE OF SUBCLINICAL ATRIAL FIBRILLATION IN STROKE PREVENTION
The increasing use of long-term cardiac monitoring in patients with cryptogenic stroke has led to a marked rise in the detection of arrhythmias, particularly subclinical atrial fibrillation (AF). While this improved detection represents a clear step forward, it also introduces new clinical uncertainty. AF has traditionally been viewed as a direct cause of thromboembolic stroke. However, emerging evidence suggests that this relationship is more complex, especially in the context of short, device-detected episodes. Major trials, including ASSERT, CRYSTAL-AF, LOOP, ARTESiA, and NOAH-AFNET 6, consistently show that although subclinical AF is associated with increased stroke risk, its detection alone does not reliably translate into improved outcomes when used as a trigger for anticoagulation under current guideline frameworks. This uncertainty is further reinforced by the lack of clear temporal association between AF episodes and stroke, as well as the absence of validated burden thresholds defining clinically meaningful arrhythmia. Concepts such as atrial cardiopathy suggest that AF may act more as a marker of an underlying prothrombotic substrate than as a direct causal mechanism. This perspective shifts the focus away from AF as a binary finding toward a model in which stroke risk emerges from the interaction between arrhythmic burden, clinical risk profile, and structural atrial disease. Taken together, these findings highlight the limitations of current AF-centered approaches and support the need for a more integrated and clinically nuanced strategy for risk stratification and treatment decisions.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessDETECTION WITHOUT DIRECTION: THE CLINICAL SIGNIFICANCE OF SUBCLINICAL ATRIAL FIBRILLATION IN STROKE PREVENTION
The increasing use of long-term cardiac monitoring in patients with cryptogenic stroke has led to a marked rise in the detection of arrhythmias, particularly subclinical atrial fibrillation (AF). While this improved detection represents a clear step forward, it also introduces new clinical uncertainty. AF has traditionally been viewed as a direct cause of thromboembolic stroke. However, emerging evidence suggests that this relationship is more complex, especially in the context of short, device-detected episodes. Major trials, including ASSERT, CRYSTAL-AF, LOOP, ARTESiA, and NOAH-AFNET 6, consistently show that although subclinical AF is associated with increased stroke risk, its detection alone does not reliably translate into improved outcomes when used as a trigger for anticoagulation under current guideline frameworks. This uncertainty is further reinforced by the lack of clear temporal association between AF episodes and stroke, as well as the absence of validated burden thresholds defining clinically meaningful arrhythmia. Concepts such as atrial cardiopathy suggest that AF may act more as a marker of an underlying prothrombotic substrate than as a direct causal mechanism. This perspective shifts the focus away from AF as a binary finding toward a model in which stroke risk emerges from the interaction between arrhythmic burden, clinical risk profile, and structural atrial disease. Taken together, these findings highlight the limitations of current AF-centered approaches and support the need for a more integrated and clinically nuanced strategy for risk stratification and treatment decisions.
- Open Access
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
DIGITAL TECHNOLOGIES, STRESS AND MENTAL HEALTH: THE ROLE OF ARTIFICIAL INTELLIGENCE AND SOCIAL MEDIA IN MODERN SOCIETY
The dynamic development of digital tools, including artificial intelligence and social media, significantly affects the functioning of modern society, also impacting mental health and stress levels. The aim of this paper was to assess the impact of using these tools on the level of stress and to analyze its health consequences, taking into account both positive and negative aspects. The study used a literature review method with elements of a systematic approach in accordance with the PRISMA guidelines. Publications from 2015 to 2025 were analyzed, mainly from the PubMed database and supplemented with other scientific sources. Ultimately, 10 articles meeting the criteria were included in the analysis. The results indicate that digital tools can significantly support healthcare by enabling real-time monitoring of health parameters, improving chronic disease management, and increasing patient engagement in the treatment process. At the same time, excessive use of social media is associated with increased levels of stress, anxiety, and depression, which is due to social comparison mechanisms and exposure to idealized content, among other things. Medical misinformation remains a significant problem, as it can lead to dangerous health decisions, including refusal of treatment. The impact of digital tools on mental health and stress levels is complex and depends primarily on the way they are used and the quality of the content available. Responsible and conscious use of technology can bring significant health benefits, while its improper use can lead to negative consequences. Therefore, further research and educational activities aimed at promoting the proper use of digital tools are necessary.
- 30 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessDIGITAL TECHNOLOGIES, STRESS AND MENTAL HEALTH: THE ROLE OF ARTIFICIAL INTELLIGENCE AND SOCIAL MEDIA IN MODERN SOCIETY
The dynamic development of digital tools, including artificial intelligence and social media, significantly affects the functioning of modern society, also impacting mental health and stress levels. The aim of this paper was to assess the impact of using these tools on the level of stress and to analyze its health consequences, taking into account both positive and negative aspects. The study used a literature review method with elements of a systematic approach in accordance with the PRISMA guidelines. Publications from 2015 to 2025 were analyzed, mainly from the PubMed database and supplemented with other scientific sources. Ultimately, 10 articles meeting the criteria were included in the analysis. The results indicate that digital tools can significantly support healthcare by enabling real-time monitoring of health parameters, improving chronic disease management, and increasing patient engagement in the treatment process. At the same time, excessive use of social media is associated with increased levels of stress, anxiety, and depression, which is due to social comparison mechanisms and exposure to idealized content, among other things. Medical misinformation remains a significant problem, as it can lead to dangerous health decisions, including refusal of treatment. The impact of digital tools on mental health and stress levels is complex and depends primarily on the way they are used and the quality of the content available. Responsible and conscious use of technology can bring significant health benefits, while its improper use can lead to negative consequences. Therefore, further research and educational activities aimed at promoting the proper use of digital tools are necessary.
- Open Access
- 19 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
INTEGRATING LASER TECHNOLOGY INTO DERMATOLOGY EDUCATION: EFFICACY, SAFETY, AND COMPTENCY-BASED TRAINING: A NARRATIVE REVIEW
The rapid advancement of laser technologies has significantly transformed contemporary dermato-logical practice, creating a growing demand for structured and competency-based education in this field. Despite the widespread clinical application of laser systems, variability in training standards and limited integration of modern educational technologies remain persistent challenges with impli-cations for both patient safety and healthcare systems. This review aims to examine the integration of laser technology into dermatology education, with a particular focus on treatment efficacy, safety considerations, and the role of technology-enhanced learning in improving clinical competency. A narrative review of recent literature was conducted, focusing on studies related to laser applications in dermatology, associated clinical outcomes, and emerging educational approaches, including simulation-based training, e-learning platforms, and virtual or augmented reality tools. The findings indicate that while laser therapies demonstrate high clinical efficacy, their safe and effective use is strongly dependent on practitioner expertise and the quality of training. Current educational models remain heterogeneous and often lack standardized competency frameworks, contributing to disparities in skill acquisition and access to high-quality training. Technology-enhanced, competency-based approaches show considerable potential in addressing these gaps by improving procedural proficiency, supporting continuous learning, and enhancing patient safety outcomes. The review highlights the need for the development of standardized, technology-integrated training frameworks that align with the evolving demands of dermatological practice. It also emphasizes broader implications for healthcare education systems, including the need to ensure equitable access to advanced training and to support lifelong learning in rapidly changing clinical environments.
- 19 June 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (2(50))
Open AccessINTEGRATING LASER TECHNOLOGY INTO DERMATOLOGY EDUCATION: EFFICACY, SAFETY, AND COMPTENCY-BASED TRAINING: A NARRATIVE REVIEW
The rapid advancement of laser technologies has significantly transformed contemporary dermato-logical practice, creating a growing demand for structured and competency-based education in this field. Despite the widespread clinical application of laser systems, variability in training standards and limited integration of modern educational technologies remain persistent challenges with impli-cations for both patient safety and healthcare systems. This review aims to examine the integration of laser technology into dermatology education, with a particular focus on treatment efficacy, safety considerations, and the role of technology-enhanced learning in improving clinical competency. A narrative review of recent literature was conducted, focusing on studies related to laser applications in dermatology, associated clinical outcomes, and emerging educational approaches, including simulation-based training, e-learning platforms, and virtual or augmented reality tools. The findings indicate that while laser therapies demonstrate high clinical efficacy, their safe and effective use is strongly dependent on practitioner expertise and the quality of training. Current educational models remain heterogeneous and often lack standardized competency frameworks, contributing to disparities in skill acquisition and access to high-quality training. Technology-enhanced, competency-based approaches show considerable potential in addressing these gaps by improving procedural proficiency, supporting continuous learning, and enhancing patient safety outcomes. The review highlights the need for the development of standardized, technology-integrated training frameworks that align with the evolving demands of dermatological practice. It also emphasizes broader implications for healthcare education systems, including the need to ensure equitable access to advanced training and to support lifelong learning in rapidly changing clinical environments.
- Open Access
- 20 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
DIGITAL HEALTH INTERVENTIONS IN TYPE 2 DIABETES: A NARRATIVE REVIEW OF PATIENT ENGAGEMENT, SELF-MANAGEMENT, AND BARRIERS TO ADOPTION
Research objective: The aim of this paper was to present the role of digital health interventions in the treatment of type 2 diabetes, with a particular focus on their impact on patient engagement, self-management, clinical outcomes, and barriers related to their implementation Methods: This study was conducted as a narrative review. The literature search was performed using PubMed and Google Scholar databases. Articles published between 2020 and 2026 were included, with priority given to systematic reviews, meta-analyses, and selected original studies concerning adult patients with type 2 diabetes. Results: Digital health interventions can improve glycemic control, with the most consistent effect being a reduction in glycated hemoglobin (HbA1c). They also support patient engagement and self-management by facilitating regular monitoring, improving adherence, and promoting healthier behaviors. The most effective interventions were those combining data monitoring with feedback and professional support. At the same time, several barriers to implementation were identified, including limited digital literacy, technological usability issues, costs, access inequalities, and insufficient integration with healthcare systems. Conclusion: Digital health interventions represent a valuable supplement to type 2 diabetes treatment. Their effectiveness depends not only on the technology itself, but also on the quality of implementation, integration with medical care, and adaptation to patients’ individual needs.
- 20 April 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 1 (2(50))
Open AccessDIGITAL HEALTH INTERVENTIONS IN TYPE 2 DIABETES: A NARRATIVE REVIEW OF PATIENT ENGAGEMENT, SELF-MANAGEMENT, AND BARRIERS TO ADOPTION
Research objective: The aim of this paper was to present the role of digital health interventions in the treatment of type 2 diabetes, with a particular focus on their impact on patient engagement, self-management, clinical outcomes, and barriers related to their implementation Methods: This study was conducted as a narrative review. The literature search was performed using PubMed and Google Scholar databases. Articles published between 2020 and 2026 were included, with priority given to systematic reviews, meta-analyses, and selected original studies concerning adult patients with type 2 diabetes. Results: Digital health interventions can improve glycemic control, with the most consistent effect being a reduction in glycated hemoglobin (HbA1c). They also support patient engagement and self-management by facilitating regular monitoring, improving adherence, and promoting healthier behaviors. The most effective interventions were those combining data monitoring with feedback and professional support. At the same time, several barriers to implementation were identified, including limited digital literacy, technological usability issues, costs, access inequalities, and insufficient integration with healthcare systems. Conclusion: Digital health interventions represent a valuable supplement to type 2 diabetes treatment. Their effectiveness depends not only on the technology itself, but also on the quality of implementation, integration with medical care, and adaptation to patients’ individual needs.